Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine vs Lidocaine for Inflammation and Pain Following Endodontic Surgery
NCT01060774Phase 4Completed
- Sponsor
- University of Maryland College Park
- Start
- Jul 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupivacaine in pain (2 arms), sponsored by University of Maryland College Park. Primary endpoint: Local inflammatory response (COX-2 and cytokines) at 48 hours. Started Jul 2008; status: completed.
02
Drugs
bupivacaine
03
Conditions
pain
Beyond the preview
Go deeper on NCT01060774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01060774.